Most trusted source for Tendering Opportunities and Business Intelligence since 2002

Ipilimumab (Doe) And Nivolumab (Doe) Medicines For All Osakidetza Service Organizations And Linked Health Centers.

Name: Ipilimumab (Doe) And Nivolumab (Doe) Medicines For All Osakidetza Service Organizations And Linked Health Centers.
Start: 2025-05-27
End: 2025-06-10
Location: Direccion General - Osakidetza

Direccion General - Osakidetza Spain has Released a tender for Ipilimumab (Doe) And Nivolumab (Doe) Medicines For All Osakidetza Service Organizations And Linked Health Centers. in Pharmaceuticals. The tender was released on May 27, 2025.

Country - Spain

Summary - Ipilimumab (Doe) And Nivolumab (Doe) Medicines For All Osakidetza Service Organizations And Linked Health Centers.

Deadline - Jun 10, 2025

GT reference number - 109663027

Product classification - Pharmaceutical products

Organization Details:

Address - Spain

Contact details - 565656565

Tender notice no. - 76454545

GT Ref Id - 109663027

Document Type - Tender Notices

Notice Details and Documents:

Description - Description: Centralized hiring of the supply of Ipilimumab (DOE) and Nivolumab (DOE) medications for all Osakidetza service organizations and health and non -profit health centers and health centers, located in the Autonomous Community of Euskadi, w ithin the frame They sign a linking agreement with Osakidetza/Basque Health Service. With this hiring file whose conditions are established in this sheet, it is intended to cover the use of the medication included in the file to meet the clinical needs of Osakidetza patients and linked centers that are summarized in the memory of the file.local title:: Suministro de los medicamentos IPILIMUMAB(DOE) y NIVOLUMAB(DOE) para todas las organizaciones d

Gt Ref Id - 109663027

Deadline - Jun 10, 2025